Paris – France – May 14, 2024 – The Alliance Promotion Microbiome (APM), a key player dedicated to the development, production, and commercialization of therapeutic innovations based on the microbiome, announces today its expansion across Europe and...
Lyon – France, November 9th, 2023 – Alliance Promotion Microbiote (APM), a leading player dedicated to the development, production, and commercialization of therapeutic innovations based on the microbiome, is proud to announce three new members. With more than 20...
Lyon, France, August 24th, 2023 – The Alliance Promotion Microbiote (APM), a prominent player dedicated to the development, production, and commercialization of therapeutic microbiome-based innovations, applauds a new legislative advancement with the publication of a...
Lyon, France, April 24, 2023, 7:30 am CET – MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with...
Outlining Path Forward for Investigational New Drug Application for MaaT013 in Patients with Acute Graft-versus-Host Disease and Reports Cash and Revenues for Fourth Quarter 2022. Access the press release...
Villejuif-Grand Paris, France, January 16, 2023 – EverImmune, a clinical-stage biotechnology company specialized in the development of live biotherapeutic products in the field of microbiota oncology, today announces that a first patient has been treated in its...
